Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (100.0%)

Trials by Status

not_yet_recruiting133%
unknown267%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruiting

sperDNA Fragmentation a a Predictor for Outcome After Varicocelectomy,m

NCT07144891
unknown

Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment

NCT05846256
unknownphase_4

Oxidative Stress In Semen And Male Infertility

NCT03464656

Clinical Trials (3)

Showing 3 of 3 trials
NCT07144891

sperDNA Fragmentation a a Predictor for Outcome After Varicocelectomy,m

Not Yet Recruiting
NCT05846256

Single and Double DNA Strand Breaks in Males With Unexplained Infertility Attending Fertility Treatment

Unknown
NCT03464656Phase 4

Oxidative Stress In Semen And Male Infertility

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3